
Global Seasonal Influenza Vaccine Market Research Report 2025(Status and Outlook)
Description
Report Overview
The seasonal influenza vaccine is a preventive healthcare product designed to protect against influenza viruses predicted to be most prevalent in a given flu season. It is typically reformulated annually to target specific strains, including Influenza A (H1N1 and H3N2) and Influenza B, based on global surveillance data from the World Health Organization (WHO) and other health authorities. The vaccine stimulates the immune system to produce antibodies, reducing the risk of infection, severe illness, and transmission. Available in various forms—such as inactivated, live-attenuated, and recombinant vaccines—it is administered via injection or nasal spray. Primarily targeting high-risk groups like the elderly, children, pregnant women, and immunocompromised individuals, it also serves as a public health tool to mitigate seasonal outbreaks. The market is driven by government immunization programs, rising awareness of preventive healthcare, and advancements in vaccine technologies. However, challenges include vaccine hesitancy, strain mismatch, and production timelines, which can impact efficacy and demand. The competitive landscape features major pharmaceutical players, with production and distribution heavily influenced by regulatory approvals and global health policies.
The global Seasonal Influenza Vaccine market size was estimated at USD 4310.49 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.12% during the forecast period.
This report provides a deep insight into the global Seasonal Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Seasonal Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Seasonal Influenza Vaccine market in any manner.
Global Seasonal Influenza Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
TaslyandJenner
Tiantan
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
Market Segmentation (by Application)
Children
Adults
Elderly
Pregnancy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Seasonal Influenza Vaccine Market
Overview of the regional outlook of the Seasonal Influenza Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Seasonal Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Seasonal Influenza Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The seasonal influenza vaccine is a preventive healthcare product designed to protect against influenza viruses predicted to be most prevalent in a given flu season. It is typically reformulated annually to target specific strains, including Influenza A (H1N1 and H3N2) and Influenza B, based on global surveillance data from the World Health Organization (WHO) and other health authorities. The vaccine stimulates the immune system to produce antibodies, reducing the risk of infection, severe illness, and transmission. Available in various forms—such as inactivated, live-attenuated, and recombinant vaccines—it is administered via injection or nasal spray. Primarily targeting high-risk groups like the elderly, children, pregnant women, and immunocompromised individuals, it also serves as a public health tool to mitigate seasonal outbreaks. The market is driven by government immunization programs, rising awareness of preventive healthcare, and advancements in vaccine technologies. However, challenges include vaccine hesitancy, strain mismatch, and production timelines, which can impact efficacy and demand. The competitive landscape features major pharmaceutical players, with production and distribution heavily influenced by regulatory approvals and global health policies.
The global Seasonal Influenza Vaccine market size was estimated at USD 4310.49 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.12% during the forecast period.
This report provides a deep insight into the global Seasonal Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Seasonal Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Seasonal Influenza Vaccine market in any manner.
Global Seasonal Influenza Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
TaslyandJenner
Tiantan
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
Market Segmentation (by Application)
Children
Adults
Elderly
Pregnancy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Seasonal Influenza Vaccine Market
Overview of the regional outlook of the Seasonal Influenza Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Seasonal Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Seasonal Influenza Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
158 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Seasonal Influenza Vaccine
- 1.2 Key Market Segments
- 1.2.1 Seasonal Influenza Vaccine Segment By Type
- 1.2.2 Seasonal Influenza Vaccine Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Seasonal Influenza Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Seasonal Influenza Vaccine Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Seasonal Influenza Vaccine Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Seasonal Influenza Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Seasonal Influenza Vaccine Product Life Cycle
- 3.3 Global Seasonal Influenza Vaccine Sales By Manufacturers (2020-2025)
- 3.4 Global Seasonal Influenza Vaccine Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Seasonal Influenza Vaccine Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Seasonal Influenza Vaccine Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Seasonal Influenza Vaccine Market Competitive Situation And Trends
- 3.8.1 Seasonal Influenza Vaccine Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Seasonal Influenza Vaccine Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Seasonal Influenza Vaccine Industry Chain Analysis
- 4.1 Seasonal Influenza Vaccine Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Seasonal Influenza Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Seasonal Influenza Vaccine Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Seasonal Influenza Vaccine Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Seasonal Influenza Vaccine Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Seasonal Influenza Vaccine Sales Market Share By Type (2020-2025)
- 6.3 Global Seasonal Influenza Vaccine Market Size Market Share By Type (2020-2025)
- 6.4 Global Seasonal Influenza Vaccine Price By Type (2020-2025)
- 7 Seasonal Influenza Vaccine Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Seasonal Influenza Vaccine Market Sales By Application (2020-2025)
- 7.3 Global Seasonal Influenza Vaccine Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Seasonal Influenza Vaccine Sales Growth Rate By Application (2020-2025)
- 8 Seasonal Influenza Vaccine Market Sales By Region
- 8.1 Global Seasonal Influenza Vaccine Sales By Region
- 8.1.1 Global Seasonal Influenza Vaccine Sales By Region
- 8.1.2 Global Seasonal Influenza Vaccine Sales Market Share By Region
- 8.2 Global Seasonal Influenza Vaccine Market Size By Region
- 8.2.1 Global Seasonal Influenza Vaccine Market Size By Region
- 8.2.2 Global Seasonal Influenza Vaccine Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Seasonal Influenza Vaccine Sales By Country
- 8.3.2 North America Seasonal Influenza Vaccine Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Seasonal Influenza Vaccine Sales By Country
- 8.4.2 Europe Seasonal Influenza Vaccine Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Seasonal Influenza Vaccine Sales By Region
- 8.5.2 Asia Pacific Seasonal Influenza Vaccine Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Seasonal Influenza Vaccine Sales By Country
- 8.6.2 South America Seasonal Influenza Vaccine Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Seasonal Influenza Vaccine Sales By Region
- 8.7.2 Middle East And Africa Seasonal Influenza Vaccine Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Seasonal Influenza Vaccine Market Production By Region
- 9.1 Global Production Of Seasonal Influenza Vaccine By Region(2020-2025)
- 9.2 Global Seasonal Influenza Vaccine Revenue Market Share By Region (2020-2025)
- 9.3 Global Seasonal Influenza Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Seasonal Influenza Vaccine Production
- 9.4.1 North America Seasonal Influenza Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Seasonal Influenza Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Seasonal Influenza Vaccine Production
- 9.5.1 Europe Seasonal Influenza Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Seasonal Influenza Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Seasonal Influenza Vaccine Production (2020-2025)
- 9.6.1 Japan Seasonal Influenza Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Seasonal Influenza Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Seasonal Influenza Vaccine Production (2020-2025)
- 9.7.1 China Seasonal Influenza Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Seasonal Influenza Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Gsk
- 10.1.1 Gsk Basic Information
- 10.1.2 Gsk Seasonal Influenza Vaccine Product Overview
- 10.1.3 Gsk Seasonal Influenza Vaccine Product Market Performance
- 10.1.4 Gsk Business Overview
- 10.1.5 Gsk Swot Analysis
- 10.1.6 Gsk Recent Developments
- 10.2 Sinovac
- 10.2.1 Sinovac Basic Information
- 10.2.2 Sinovac Seasonal Influenza Vaccine Product Overview
- 10.2.3 Sinovac Seasonal Influenza Vaccine Product Market Performance
- 10.2.4 Sinovac Business Overview
- 10.2.5 Sinovac Swot Analysis
- 10.2.6 Sinovac Recent Developments
- 10.3 Changsheng
- 10.3.1 Changsheng Basic Information
- 10.3.2 Changsheng Seasonal Influenza Vaccine Product Overview
- 10.3.3 Changsheng Seasonal Influenza Vaccine Product Market Performance
- 10.3.4 Changsheng Business Overview
- 10.3.5 Changsheng Swot Analysis
- 10.3.6 Changsheng Recent Developments
- 10.4 Ccbio
- 10.4.1 Ccbio Basic Information
- 10.4.2 Ccbio Seasonal Influenza Vaccine Product Overview
- 10.4.3 Ccbio Seasonal Influenza Vaccine Product Market Performance
- 10.4.4 Ccbio Business Overview
- 10.4.5 Ccbio Recent Developments
- 10.5 Aleph Biomedical
- 10.5.1 Aleph Biomedical Basic Information
- 10.5.2 Aleph Biomedical Seasonal Influenza Vaccine Product Overview
- 10.5.3 Aleph Biomedical Seasonal Influenza Vaccine Product Market Performance
- 10.5.4 Aleph Biomedical Business Overview
- 10.5.5 Aleph Biomedical Recent Developments
- 10.6 Sanofi
- 10.6.1 Sanofi Basic Information
- 10.6.2 Sanofi Seasonal Influenza Vaccine Product Overview
- 10.6.3 Sanofi Seasonal Influenza Vaccine Product Market Performance
- 10.6.4 Sanofi Business Overview
- 10.6.5 Sanofi Recent Developments
- 10.7 Lanzhou Institute Of Biological Product
- 10.7.1 Lanzhou Institute Of Biological Product Basic Information
- 10.7.2 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Product Overview
- 10.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Product Market Performance
- 10.7.4 Lanzhou Institute Of Biological Product Business Overview
- 10.7.5 Lanzhou Institute Of Biological Product Recent Developments
- 10.8 Siobp
- 10.8.1 Siobp Basic Information
- 10.8.2 Siobp Seasonal Influenza Vaccine Product Overview
- 10.8.3 Siobp Seasonal Influenza Vaccine Product Market Performance
- 10.8.4 Siobp Business Overview
- 10.8.5 Siobp Recent Developments
- 10.9 Hualan Bio
- 10.9.1 Hualan Bio Basic Information
- 10.9.2 Hualan Bio Seasonal Influenza Vaccine Product Overview
- 10.9.3 Hualan Bio Seasonal Influenza Vaccine Product Market Performance
- 10.9.4 Hualan Bio Business Overview
- 10.9.5 Hualan Bio Recent Developments
- 10.10 Tianyuan Bio-pharma
- 10.10.1 Tianyuan Bio-pharma Basic Information
- 10.10.2 Tianyuan Bio-pharma Seasonal Influenza Vaccine Product Overview
- 10.10.3 Tianyuan Bio-pharma Seasonal Influenza Vaccine Product Market Performance
- 10.10.4 Tianyuan Bio-pharma Business Overview
- 10.10.5 Tianyuan Bio-pharma Recent Developments
- 10.11 Vaxtec
- 10.11.1 Vaxtec Basic Information
- 10.11.2 Vaxtec Seasonal Influenza Vaccine Product Overview
- 10.11.3 Vaxtec Seasonal Influenza Vaccine Product Market Performance
- 10.11.4 Vaxtec Business Overview
- 10.11.5 Vaxtec Recent Developments
- 10.12 Hissen
- 10.12.1 Hissen Basic Information
- 10.12.2 Hissen Seasonal Influenza Vaccine Product Overview
- 10.12.3 Hissen Seasonal Influenza Vaccine Product Market Performance
- 10.12.4 Hissen Business Overview
- 10.12.5 Hissen Recent Developments
- 10.13 Abbott
- 10.13.1 Abbott Basic Information
- 10.13.2 Abbott Seasonal Influenza Vaccine Product Overview
- 10.13.3 Abbott Seasonal Influenza Vaccine Product Market Performance
- 10.13.4 Abbott Business Overview
- 10.13.5 Abbott Recent Developments
- 10.14 Novartis
- 10.14.1 Novartis Basic Information
- 10.14.2 Novartis Seasonal Influenza Vaccine Product Overview
- 10.14.3 Novartis Seasonal Influenza Vaccine Product Market Performance
- 10.14.4 Novartis Business Overview
- 10.14.5 Novartis Recent Developments
- 10.15 Taslyandjenner
- 10.15.1 Taslyandjenner Basic Information
- 10.15.2 Taslyandjenner Seasonal Influenza Vaccine Product Overview
- 10.15.3 Taslyandjenner Seasonal Influenza Vaccine Product Market Performance
- 10.15.4 Taslyandjenner Business Overview
- 10.15.5 Taslyandjenner Recent Developments
- 10.16 Tiantan
- 10.16.1 Tiantan Basic Information
- 10.16.2 Tiantan Seasonal Influenza Vaccine Product Overview
- 10.16.3 Tiantan Seasonal Influenza Vaccine Product Market Performance
- 10.16.4 Tiantan Business Overview
- 10.16.5 Tiantan Recent Developments
- 11 Seasonal Influenza Vaccine Market Forecast By Region
- 11.1 Global Seasonal Influenza Vaccine Market Size Forecast
- 11.2 Global Seasonal Influenza Vaccine Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Seasonal Influenza Vaccine Market Size Forecast By Country
- 11.2.3 Asia Pacific Seasonal Influenza Vaccine Market Size Forecast By Region
- 11.2.4 South America Seasonal Influenza Vaccine Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Seasonal Influenza Vaccine By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Seasonal Influenza Vaccine Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Seasonal Influenza Vaccine By Type (2026-2033)
- 12.1.2 Global Seasonal Influenza Vaccine Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Seasonal Influenza Vaccine By Type (2026-2033)
- 12.2 Global Seasonal Influenza Vaccine Market Forecast By Application (2026-2033)
- 12.2.1 Global Seasonal Influenza Vaccine Sales (K Mt) Forecast By Application
- 12.2.2 Global Seasonal Influenza Vaccine Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.